<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36112333</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2509-2723</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>GeroScience</Title><ISOAbbreviation>Geroscience</ISOAbbreviation></Journal><ArticleTitle>The majority of severe COVID-19 patients develop anti-cardiac autoantibodies.</ArticleTitle><Pagination><StartPage>2347</StartPage><EndPage>2360</EndPage><MedlinePgn>2347-2360</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11357-022-00649-6</ELocationID><Abstract><AbstractText>Severe cases of COVID-19 are characterized by an inflammatory burst, which is accompanied by multiorgan failure. The elderly population has higher risk for severe or fatal outcome for COVID-19. Inflammatory mediators facilitate the immune system to combat viral infection by producing antibodies against viral antigens. Several studies reported that the pro-inflammatory state and tissue damage in COVID-19 also promotes autoimmunity by autoantibody generation. We hypothesized that a subset of these autoantibodies targets cardiac antigens. Here we aimed to detect anti-cardiac autoantibodies in severe COVID-19 patients during hospitalization. For this purpose, 104 COVID-19 patients were recruited, while 40 heart failure patients with dilated cardiomyopathy and 20 patients with severe aortic stenosis served as controls. Patients were tested for anti-cardiac autoantibodies, using human heart homogenate as a bait. Follow-up samples were available in 29 COVID-19 patients. Anti-cardiac autoantibodies were detected in 68% (71 out of 104) of severe COVID-19 patients. Overall, 39% of COVID-19 patients had anti-cardiac IgG autoantibodies, while 51% had anti-cardiac autoantibodies of IgM isotype. Both IgG and IgM anti-cardiac autoantibodies were observed in 22% of cases, and multiple cardiac antigens were targeted in 38% of COVID-19 patients. These anti-cardiac autoantibodies targeted a diverse set of myocardial proteins, without apparent selectivity. As controls, heart failure patients (with dilated cardiomyopathy) had similar occurrence of IgG (45%, p&#x2009;=&#x2009;0.57) autoantibodies, while significantly lower occurrence of IgM autoantibodies (30%, p&#x2009;=&#x2009;0.03). Patients with advanced aortic stenosis had significantly lower number of both IgG (11%, p&#x2009;=&#x2009;0.03) and IgM (10%, p&#x2009;&lt;&#x2009;0.01) type anti-cardiac autoantibodies than that in COVID-19 patients. Furthermore, we detected changes in the anti-cardiac autoantibody profile in 7 COVID-19 patients during hospital treatment. Surprisingly, the presence of these anti-cardiac autoantibodies did not affect the clinical outcome and the prevalence of the autoantibodies did not differ between the elderly (over 65&#xa0;years) and the patients younger than 65&#xa0;years of age. Our results demonstrate that the majority of hospitalized COVID-19 patients produce novel anti-cardiac IgM autoantibodies. COVID-19 also reactivates resident IgG autoantibodies. These autoantibodies may promote autoimmune reactions, which can complicate post-COVID recuperation, contributing to post-acute sequelae of COVID-19 (long COVID).</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Fagyas</LastName><ForeName>Mikl&#xf3;s</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HAS-UD Vascular Biology and Myocardial Pathophysiology Research Group, Hungarian Academy of Sciences, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Molecular Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Nagy</LastName><ForeName>B&#xe9;la</ForeName><Initials>B</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xe1;duly</LastName><ForeName>Arnold P&#xe9;ter</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>K&#xe1;lm&#xe1;n Laki Doctoral School, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe1;nyin&#xe9;</LastName><ForeName>Ivetta Siket</ForeName><Initials>IS</Initials><AffiliationInfo><Affiliation>Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe1;rtha</LastName><ForeName>Lilla</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erd&#x151;si</LastName><ForeName>G&#xe1;bor</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sipka</LastName><ForeName>S&#xe1;ndor</ForeName><Initials>S</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Division of Cardiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Enyedi</LastName><ForeName>Enik&#x151;</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>K&#xe1;lm&#xe1;n Laki Doctoral School, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szab&#xf3;</LastName><ForeName>Attila &#xc1;d&#xe1;m</ForeName><Initials>A&#xc1;</Initials><AffiliationInfo><Affiliation>Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>K&#xe1;lm&#xe1;n Laki Doctoral School, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xf3;lik</LastName><ForeName>Zs&#xf3;fia</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kappelmayer</LastName><ForeName>J&#xe1;nos</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papp</LastName><ForeName>Zolt&#xe1;n</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HAS-UD Vascular Biology and Myocardial Pathophysiology Research Group, Hungarian Academy of Sciences, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Molecular Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borb&#xe9;ly</LastName><ForeName>Attila</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szab&#xf3;</LastName><ForeName>Tam&#xe1;s</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balla</LastName><ForeName>J&#xf3;zsef</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>HAS-UD Vascular Biology and Myocardial Pathophysiology Research Group, Hungarian Academy of Sciences, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balla</LastName><ForeName>Gy&#xf6;rgy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>HAS-UD Vascular Biology and Myocardial Pathophysiology Research Group, Hungarian Academy of Sciences, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Bai</LastName><ForeName>P&#xe9;ter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Research Center for Molecular Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Chemistry, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MTA-DE Lend&#xfc;let Laboratory of Cellular Metabolism, Debrecen, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MTA-DE Cell Biology and Signaling Research Group ELKH, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>B&#xe1;csi</LastName><ForeName>Attila</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ELKH-DE Allergology Research Group, Debrecen, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>T&#xf3;th</LastName><ForeName>Attila</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6503-3653</Identifier><AffiliationInfo><Affiliation>Division of Clinical Physiology, Department of Cardiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. atitoth@med.unideb.hu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HAS-UD Vascular Biology and Myocardial Pathophysiology Research Group, Hungarian Academy of Sciences, Budapest, Hungary. atitoth@med.unideb.hu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Molecular Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. atitoth@med.unideb.hu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Geroscience</MedlineTA><NlmUniqueID>101686284</NlmUniqueID><ISSNLinking>2509-2723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007075">Immunoglobulin M</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002311" MajorTopicYN="Y">Cardiomyopathy, Dilated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007075" MajorTopicYN="N">Immunoglobulin M</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="Y">Aortic Valve Stenosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anti-cardiac autoantibodies</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>16</Day><Hour>11</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36112333</ArticleId><ArticleId IdType="pmc">PMC9483490</ArticleId><ArticleId IdType="doi">10.1007/s11357-022-00649-6</ArticleId><ArticleId IdType="pii">10.1007/s11357-022-00649-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nikolich-Zugich J, Knox KS, Rios CT, et al. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. GeroScience. 2020;42:505&#x2013;514. doi: 10.1007/s11357-020-00186-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-020-00186-0</ArticleId><ArticleId IdType="pmc">PMC7145538</ArticleId><ArticleId IdType="pubmed">32274617</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan A, Hamilton JP, Alqahtani SA, A. Woreta T, A narrative review of coronavirus disease 2019 (COVID-19) clinical epidemiological characteristics and systemic manifestations. Intern Emerg Med. 2021;16:815&#x2013;830. doi: 10.1007/s11739-020-02616-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-020-02616-5</ArticleId><ArticleId IdType="pmc">PMC7811158</ArticleId><ArticleId IdType="pubmed">33453010</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Diabetes &amp; metabolic syndrome: clinical research &amp; reviews long COVID: an overview. Diabetes Metab Syndr Clin Res Rev. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC9637465</ArticleId><ArticleId IdType="pubmed">36351871</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, Group for the GAC-19 P-ACS Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among [1] M. W. Tenforde et al., Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network &#x2014; united. MMWR Morb Mortal Wkly Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris SB, Schwartz NG, Patel P, et al. Case series of multisystem inflammatory syndrome in adults associated with SARS-CoV-2 infection &#x2014; United Kingdom and United States. MMWR Morb Mortal Wkly Rep. 2020;69:1450&#x2013;1456. doi: 10.15585/mmwr.mm6940e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6940e1</ArticleId><ArticleId IdType="pmc">PMC7561225</ArticleId><ArticleId IdType="pubmed">33031361</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlachoyiannopoulos PG, Magira E, Alexopoulos H, et al. Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19. Ann Rheum Dis. 2020;79:1661&#x2013;1663. doi: 10.1136/annrheumdis-2020-218009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218009</ArticleId><ArticleId IdType="pubmed">32581086</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, et al.&#xa0;Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370. 10.1126/science.abd4585</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Combes AJ, Courau T, Kuhn NF, et al. Global absence and targeting of protective immune states in severe COVID-19. Nature. 2021;591:124&#x2013;130. doi: 10.1038/s41586-021-03234-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03234-7</ArticleId><ArticleId IdType="pmc">PMC8567458</ArticleId><ArticleId IdType="pubmed">33494096</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagyas M, Fejes Z, S&#xfc;t&#x151; R, et al. Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients. Int J Infect Dis. 2022;115:8&#x2013;16. doi: 10.1016/j.ijid.2021.11.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.11.028</ArticleId><ArticleId IdType="pmc">PMC8613979</ArticleId><ArticleId IdType="pubmed">34838959</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagyas M, B&#xe1;nhegyi V, &#xda;ri K, et al. Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patients. GeroScience. 2021;43:2289&#x2013;2304. doi: 10.1007/s11357-021-00467-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-021-00467-2</ArticleId><ArticleId IdType="pmc">PMC8529378</ArticleId><ArticleId IdType="pubmed">34674152</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagyas M, Kert&#xe9;sz A, Siket IM, et al. Level of the SARS-CoV-2 receptor ACE2 activity is highly elevated in old-aged patients with aortic stenosis: implications for ACE2 as a biomarker for the severity of COVID-19. GeroScience. 2021;43:19&#x2013;29. doi: 10.1007/s11357-020-00300-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-020-00300-2</ArticleId><ArticleId IdType="pmc">PMC7815502</ArticleId><ArticleId IdType="pubmed">33469835</ArticleId></ArticleIdList></Reference><Reference><Citation>Rueden CT, Schindelin J, Hiner MC, et al. Image J2: ImageJ for the next generation of scientific image data. BMC Bioinformatics. 2017;18:529. doi: 10.1186/s12859-017-1934-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-017-1934-z</ArticleId><ArticleId IdType="pmc">PMC5708080</ArticleId><ArticleId IdType="pubmed">29187165</ArticleId></ArticleIdList></Reference><Reference><Citation>Muniz BC, Milito MA, Marchiori E. COVID-19-computed tomography findings in two patients in Petr&#xf3;polis, Rio de Janeiro, Brazil. Rev Soc Bras Med Trop. 2020;53:3&#x2013;4. doi: 10.1590/0037-8682-0147-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0037-8682-0147-2020</ArticleId><ArticleId IdType="pmc">PMC7182289</ArticleId><ArticleId IdType="pubmed">32321099</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagiannis D, Steinestel J, Hackenbroch C, et al. Clinical, serological, and histopathological similarities between severe COVID-19 and acute exacerbation of connective tissue disease-associated interstitial lung disease (CTD-ILD) Front Immunol. 2020;11:1&#x2013;11. doi: 10.3389/fimmu.2020.587517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.587517</ArticleId><ArticleId IdType="pmc">PMC7566417</ArticleId><ArticleId IdType="pubmed">33123171</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et al.&#xa0;Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2020. 10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109:531&#x2013;538. doi: 10.1007/s00392-020-01626-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-020-01626-9</ArticleId><ArticleId IdType="pmc">PMC7087935</ArticleId><ArticleId IdType="pubmed">32161990</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixit NM, Churchill A, Nsair A, Hsu JJ. Post-acute COVID-19 syndrome and the cardiovascular system: what is known? Am Hear J Plus Cardiol Res Pract. 2021;5:100025. doi: 10.1016/j.ahjo.2021.100025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahjo.2021.100025</ArticleId><ArticleId IdType="pmc">PMC8223036</ArticleId><ArticleId IdType="pubmed">34192289</ArticleId></ArticleIdList></Reference><Reference><Citation>Caforio ALP, Tona F, Bottaro S, et al. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity. 2008;41:35&#x2013;45. doi: 10.1080/08916930701619235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930701619235</ArticleId><ArticleId IdType="pubmed">18176863</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H-C, Huang KTL, Wang X-L, Shen W-K. Autoantibodies and cardiac arrhythmias. Hear Rhythm. 2011;8:1788&#x2013;1795. doi: 10.1016/j.hrthm.2011.06.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2011.06.032</ArticleId><ArticleId IdType="pmc">PMC3855646</ArticleId><ArticleId IdType="pubmed">21740882</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SE, Feng A, Meng W, et al. New-onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun. 2021;12:5417. doi: 10.1038/s41467-021-25509-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25509-3</ArticleId><ArticleId IdType="pmc">PMC8440763</ArticleId><ArticleId IdType="pubmed">34521836</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruber CN, Patel RS, Trachtman R, et al. Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C) Cell. 2020;183:982&#x2013;995.e14. doi: 10.1016/j.cell.2020.09.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.034</ArticleId><ArticleId IdType="pmc">PMC7489877</ArticleId><ArticleId IdType="pubmed">32991843</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>